Status:
COMPLETED
HOBSCOTCH Phase III
Lead Sponsor:
Dartmouth-Hitchcock Medical Center
Collaborating Sponsors:
Centers for Disease Control and Prevention
Conditions:
Epilepsy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine the efficacy of an entirely virtual version of the home-based cognitive self-management program "HOBSCOTCH." It will test whether HOBSCOTCH can be delivered n...
Detailed Description
HOBSCOTCH (Home Based Self-management and Cognitive Training Changes lives) is a home-based self-management program to treat cognitive symptoms and improve quality of life, while minimizing the barrie...
Eligibility Criteria
Inclusion
- Age 18+
- Diagnosis of epilepsy, with controlled or uncontrolled seizures
- Subjective memory complaints
- No changes in antiepileptic and antidepressant medication regimen for 1 month, however brief discontinuation of antiepileptic medicine for inpatient video EEG evaluation is acceptable
- Literate
- Telephone access
- Internet access
Exclusion
- Subjects self-reporting a dementing illness or a mention of a dementing illness in their medical record
- Severe mental disability or estimated IQ less than 70 per clinical judgement
- Significant visual impairment precluding reading or writing
- No reliable telephone or internet access
- No diagnosis of epilepsy
Key Trial Info
Start Date :
November 12 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 19 2024
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT04519775
Start Date
November 12 2020
End Date
November 19 2024
Last Update
July 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States, 03756